The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

Conference on HIV Science officially opened Monday in the Rwandan capital of Kigali, with a strong call to accelerate access to long-acting HIV prevention and treatment innovations amid growing global ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Global health leaders and advocates challenged attendees of IAS to support the work of the partnerships that are creating patient-focused innovations for HIV prevention and treatment.

The World Health Organization (WHO) is recommending a twice-yearly injection of lenacapavir for prevention of HIV, according to a press release .

Scientists, researchers, policy makers and HIV/AIDS advocates at a meeting in Kigali, Rwanda, from July 13-17 for the 13th International AIDS Conference on HIV Science (IAS 2025), have raised an alarm ...

The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice ...

New data from Africa and Latin America shows rising infections, stalled treatment, and strained health systems Kampala, Uganda | RONALD MUSOKE | Scientists, researchers, policy makers and HIV/AIDS ...

Global progress against AIDS is at risk as US funding cuts threaten life-saving programs. Experts warn of millions of ...

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, will remind the world that HIV/AIDS is not over by showcasing its innovative, client-centered approaches to the prevention, care ...

The temporary suspension of PEPFAR has disrupted preventive treatments, infant testing, and the work of community health ...

WHO has officially recommended twice-yearly injectable lenacapavir for HIV prevention, marking a major shift in global HIV ...